Hologic stock heads into the open after a modest gain
Published on 09/14/2026 at 03:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hologic stock closed at USD 74.39 on the Nasdaq on September 11, 2026, up 0.4% from the prior session according to Nasdaq data from a major financial portal. This move kept the shares within their recent range while health care peers showed mixed performance relative to the broader market.
September 11, 2026 in numbers
Hologic Inc. (ISIN US4364401012) ended the September 11, 2026 session at USD 74.39 on the Nasdaq, compared with a prior close of USD 74.10, which translates into a 0.4% daily gain per Nasdaq quote data. Intraday, the stock traded between a low of USD 73.60 and a high of USD 74.80, keeping the close near the upper half of the day range. Trading volume for the session reached roughly 1.1 million shares, below the recent daily average that has prevailed when company specific news was in focus. Over the past 52 weeks, the share price has traded between about USD 64 and USD 84, placing the latest close closer to the middle of that band and leaving room in both directions for future moves.
On September 11, 2026, the S&P 500 index closed marginally higher while many health care names moved in a narrow band. The slight gain in Hologic shares meant the stock underperformed the strongest health care winners of the day but broadly tracked the index level move, suggesting a session driven more by general market sentiment than by company specific headlines.
Today’s drivers for Hologic stock
Today, Hologic shares head into the open without a scheduled earnings release during this session in the mainstream earnings calendars, leaving macroeconomic and sector indicators as the primary potential influences. Economic calendars from portals such as Investing.com highlight data releases on inflation and industrial activity around September 14, 2026, which can affect interest rate expectations and valuations for medical technology companies. Broader health care sector sentiment, as reflected in performance tables such as the return on assets ranking from StockTitan, also frames how investors position in Hologic relative to peers today.
